News Search

Dr. Andrew Lassman: "These trials transformed our understanding of the clinical behavior of molecularly defined gliomas and contributed to the classification of gliomas used globally today."

A new study by Iok In Christine Chio, PhD, provides key insights towards a possible treatment that can toggle this molecular switch to block the spread of pancreatic cancer to other organs.

"In the next wave of precision medicine, treating cancer will depend on our ability to be even more predictive with our approaches," writes Dr. Andrea Califano in our latest Disruptors column.

Congratulations to Dr. Vasan, one of four physician-scientists named a Gerstner Scholar. This recognition gives early-career scientists vital funding to conduct pioneering research.